Johnson & Johnson (JNJ) Updates FY14 Earnings Guidance
Johnson & Johnson (NYSE:JNJ) issued an update on its FY14 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $5.80-5.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.83, American Banking News reports.
Johnson & Johnson (NYSE:JNJ) opened at 97.14 on Tuesday. Johnson & Johnson has a 52-week low of $82.07 and a 52-week high of $99.38. The stock’s 50-day moving average is $94.97 and its 200-day moving average is $92.73. The company has a market cap of $274.8 billion and a P/E ratio of 20.14. Johnson & Johnson also saw a large growth in short interest during the month of January. As of March 31st, there was short interest totalling 31,078,666 shares, a growth of 9.6% from the March 14th total of 28,349,984 shares. Based on an average trading volume of 10,166,169 shares, the short-interest ratio is presently 3.1 days. Approximately 1.1% of the shares of the stock are sold short.
Johnson & Johnson (NYSE:JNJ) last released its earnings data on Tuesday, April 15th. The company reported $1.54 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.48 by $0.06. The company had revenue of $18.10 billion for the quarter, compared to the consensus estimate of $18.00 billion. During the same quarter last year, the company posted $1.44 earnings per share. Johnson & Johnson’s revenue was up 3.5% compared to the same quarter last year. Analysts expect that Johnson & Johnson will post $5.83 EPS for the current fiscal year.
JNJ has been the subject of a number of recent research reports. Analysts at Jefferies Group downgraded shares of Johnson & Johnson from a buy rating to a hold rating in a research note on Monday. They now have a $105.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Zacks reiterated a neutral rating on shares of Johnson & Johnson in a research note on Monday, February 17th. They now have a $97.00 price target on the stock. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of $76.92.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.